Antares Pharma (ATRS +11%) jumps after reporting positive results from its Actual Human Use...


Antares Pharma (ATRS +11%) jumps after reporting positive results from its Actual Human Use study, to assess the effectiveness of self-administered Vibex Methotrexate for adult patients with rheumatoid arthritis. The company said that the results show that self-administration of the drug is safe and well tolerated. All 101 patients were able to self-administer the medication successfully following standardized training and review of written instructions.

From other sites
Comments (4)
  • djbigley
    , contributor
    Comments (115) | Send Message
     
    Loving it.
    25 Sep 2012, 12:25 PM Reply Like
  • vitosoranno1
    , contributor
    Comments (1632) | Send Message
     
    Up, up and away .........................
    25 Sep 2012, 12:32 PM Reply Like
  • dsnizzlemynizzle
    , contributor
    Comment (1) | Send Message
     
    Antares is on the move! When is the planned NDA filing?
    25 Sep 2012, 05:30 PM Reply Like
  • djbigley
    , contributor
    Comments (115) | Send Message
     
    hmmm... a lot of retrace yesterday.
    26 Sep 2012, 12:03 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs